Golding H - Search Results

1

Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.

Van Epps P, Tumpey T, Pearce MB, Golding H, Higgins P, Hornick T, Burant C, Wilson BM, Banks R, Gravenstein S, Canaday DH. Van Epps P, et al. Among authors: golding h. Clin Vaccine Immunol. 2017 Mar 6;24(3):e00498-16. doi: 10.1128/CVI.00498-16. Print 2017 Mar. Clin Vaccine Immunol. 2017. PMID: 28100496 Free PMC article.

2

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007.

Eichelberger M, Golding H, Hess M, Weir J, Subbarao K, Luke CJ, Friede M, Wood D. Eichelberger M, et al. Among authors: golding h. Vaccine. 2008 Aug 12;26(34):4299-303. doi: 10.1016/j.vaccine.2008.06.012. Epub 2008 Jun 26. Vaccine. 2008. PMID: 18582523

3

Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.

Meseda CA, Mayer AE, Kumar A, Garcia AD, Campbell J, Listrani P, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP. Meseda CA, et al. Among authors: golding h. Clin Vaccine Immunol. 2009 Sep;16(9):1261-71. doi: 10.1128/CVI.00040-09. Epub 2009 Jul 15. Clin Vaccine Immunol. 2009. PMID: 19605597 Free PMC article.

4

A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses.

Hassantoufighi A, Zhang H, Sandbulte M, Gao J, Manischewitz J, King L, Golding H, Straight TM, Eichelberger MC. Hassantoufighi A, et al. Among authors: golding h. Vaccine. 2010 Jan 8;28(3):790-7. doi: 10.1016/j.vaccine.2009.10.066. Epub 2009 Nov 1. Vaccine. 2010. PMID: 19887135

5

Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines.

Khurana S, Larkin C, Verma S, Joshi MB, Fontana J, Steven AC, King LR, Manischewitz J, McCormick W, Gupta RK, Golding H. Khurana S, et al. Among authors: golding h. Vaccine. 2011 Aug 5;29(34):5657-65. doi: 10.1016/j.vaccine.2011.06.014. Epub 2011 Jun 23. Vaccine. 2011. PMID: 21704111 Free PMC article.

6

Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.

Khurana S, Verma N, Talaat KR, Karron RA, Golding H. Khurana S, et al. Among authors: golding h. J Infect Dis. 2012 Feb 15;205(4):610-20. doi: 10.1093/infdis/jir791. Epub 2011 Dec 29. J Infect Dis. 2012. PMID: 22207649

7

Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infection.

Fuentes S, Crim RL, Beeler J, Teng MN, Golding H, Khurana S. Fuentes S, et al. Among authors: golding h. Vaccine. 2013 Aug 20;31(37):3987-94. doi: 10.1016/j.vaccine.2013.05.088. Epub 2013 Jun 4. Vaccine. 2013. PMID: 23742994 Free PMC article.

8

A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.

Talaat KR, Luke CJ, Khurana S, Manischewitz J, King LR, McMahon BA, Karron RA, Lewis KD, Qin J, Follmann DA, Golding H, Neuzil KM, Subbarao K. Talaat KR, et al. Among authors: golding h. J Infect Dis. 2014 Jun 15;209(12):1860-9. doi: 10.1093/infdis/jiu123. Epub 2014 Mar 5. J Infect Dis. 2014. PMID: 24604819 Free PMC article. Clinical Trial.

9

Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency.

Khurana S, King LR, Manischewitz J, Coyle EM, Golding H. Khurana S, et al. Among authors: golding h. Vaccine. 2014 Apr 17;32(19):2188-97. doi: 10.1016/j.vaccine.2014.02.049. Epub 2014 Mar 6. Vaccine. 2014. PMID: 24613520

10

H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.

Khurana S, Coyle EM, Verma S, King LR, Manischewitz J, Crevar CJ, Carter DM, Ross TM, Golding H. Khurana S, et al. Among authors: golding h. Vaccine. 2014 Nov 12;32(48):6421-32. doi: 10.1016/j.vaccine.2014.09.049. Epub 2014 Oct 3. Vaccine. 2014. PMID: 25284811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters